<DOC>
	<DOCNO>NCT00715117</DOCNO>
	<brief_summary>It hypothesize oral naltrexone improve inflammation bowel increase endogenous enkephalin level subject active Crohn 's disease . This especially important child often suffer nutritional deprivation retard growth . The key objective : 1 . Evaluate effect low dose naltrexone child Crohn 's Disease use Pediatric Crohn 's Disease Activity Index ( PCDAI ) , plasma inflammatory marker , weight , pediatric quality life survey . 2 . To determine safety toxicity low dose naltrexone pediatric subject active Crohn 's Disease . 3 . Assess potential mechanism naltrexone exert action measure plasma opioid ( enkephalin endorphin level ) proinflammatory cytokine .</brief_summary>
	<brief_title>The Efficacy Low Dose Naltrexone Therapy Children With Crohn 's Disease</brief_title>
	<detailed_description>The present proposal design double-blinded placebo control study involve 30 child 6-17 year age active Crohn 's disease . Children treat either naltrexone placebo first 8 week subject receive active naltrexone drug last 8 week . A one month follow-up appointment schedule 4-weeks completion active drug safety ass Crohn 's activity . Low dose naltrexone ( LDN ) dispense either capsule dose 4.5 mg age 10 year old liquid form 0.1 mg/kg age 10 less 45 kg . Half subject first 8 week randomize placebo either capsule fill avicel ( see section 6.0 ) diluent ( flavored water ) liquid form . Children eligible child-bearing potential use two mean effective birth control , Pediatric Crohn 's Disease Activity Index ( PCDAI ) least 31 point , confirm diagnosis Crohn 's disease either endoscopic radiographic test .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>All subject must give write informed consent parent guardian Male female subject , &gt; 6 17 year Patients must endoscopic radiographic confirm Crohn 's Disease . Patients must Pediatric Crohn 's Disease Activity Index ( PCDAI ) least 31 . Adolescent woman childbearing potential / sexually active unless surgically sterile use adequate contraception ( either IUD , oral deport contraceptive , barrier plus spermicide ) , willing able continue contraception 3 month completion study . Adolescent woman pregnant breastfeeding Subjects ostomy ileocolic anastomosis surgery operation interfere PCDAI assessment Subjects take tacrolimus , cyclosporin , mycophenolate , antiTNFÎ± therapy must discontinue 4 week prior study initiation . Patients abnormal liver function test Prednisone great 10 mg &gt; 0.2 mg/kg orally</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>child</keyword>
	<keyword>pediatric</keyword>
	<keyword>Crohn 's Disease</keyword>
	<keyword>naltrexone</keyword>
	<keyword>LDN</keyword>
	<keyword>IBD</keyword>
	<keyword>Inflammatory bowel disease</keyword>
</DOC>